Objective: To study the mechanism of Banxia Xiexin decoction and its disassembled prescriptions on improving intestinal immunity of patients with inflammatory bowel disease (IBD). Methods: The active ingredients and targets of Banxia Xiexin decoction and its disassembled prescriptions were screened out from the Traditional Chinese Medicine System Pharmacology Database (TCMSP). Genecards and OMMI databases were used to screen potential targets related to inflammatory bowel disease. After intersection, Cytoscape 3.7.0 was used to make the active ingredient-target network chart, and the protein-protein interaction (PPI) network was drawn with String, and the signal pathway between drugs and inflammatory bowel disease was analyzed using GO and KEGG pathway enrichment analysis. Results: There were 129 active components in Banxia Xiexin decoction, 43 in Xinkai (Banxia + dried ginger) group, 104 in Kujiang (radix scutellariae + coptidis rhizoma) group and 121 in Ganbu (ginseng + radix glycyrrhizae + jujube) group. Further analysis found that Quercetin, Beta sitosterol, Kaemoferol, Stigmasterol, Baicalein and other active components in Banxia Xiexin Decoction group were closely related to PTGS1, AR, ESR1, PRSS1, PPARG and other IBD disease targets, and may be involved in the regulation through AGE-RAGE and TNF signaling pathway. In Xinkai group, the results showed that β-sitosterol, Baicalein, Stigmasterol, Cavendine), Coniferin and other active components were related to PTGS1, Chrm1, Chrm3, PGR, AR targets, and involved in P53 signaling pathway. Quercetin, Baicalein, Wogonin, Beta-sitosterol, Acacetin in Kujiang group were related to PTGS1, AR, PRSS1, ESR1 and CHEK1 targets, and involved in P13K-Akt, AGE-RAGE, P53 and TNF signaling pathway. In Ganbu group, Quercetin, Kaemoferol, β-sitosterol, Stigmasterol, Isorhamnetin and other active components were related to ESR1, PPARG, AR, PTGS1 and PRSS1 targets, and involved in AGE-RAGE and TNF signaling pathway by playing a role of anti-apoptosis, anti-inflammatory, and enhancing intestinal immunity to inhibit the occurrence and development of IBD. Conclusion: Banxia Xiexin decoction and its disassembled prescriptions could improve IBD for their multi-component, multi-target and multi pharmacological effects.
[1] Shapiro JM, Subedi S, LeLeiko NS. Inflammatory bowel disease[J]. Pediatr Rev, 2016, 37(8): 337-347.
[2] Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review[J]. Gastroenterology, 2012, 142(1): 46-54, e30.
[3] Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region[J]. Curr Opin Gastroenterol, 2005, 21(4): 408-413.
[4] O'Toole A, Korzenik J. Environmental triggers for IBD[J]. Curr Gastroenterol Rep, 2014, 16(7): 396.
[5] Halmos EP, Gibson PR. Dietary management of IBD-insights and advice[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(3): 133-146.
[6] Cho JH, Weaver CT. The genetics of inflammatory bowel disease[J]. Gastroenterology, 2007, 133(4): 1327-1339.
[7] Connelly TM, Berg AS, Harris LR, et al. Genetic determinants associated with early age of diagnosis of IBD[J]. Dis Colon Rectum, 2015, 58(3): 321-327.
[8] Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease[J]. Nature, 2007, 448(7152): 427-434.
[9] Mangan PR, Harrington LE, O’Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage[J]. Nature, 2006, 441(7090): 231-234.
[10] Mikhailov TA, Furner SE. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children[J]. World J Gastroenterol, 2009, 15(3): 270-279.
[11] 鲍海琴, 陈本启, 赵伟, 等. 半夏泻心汤对重症急性胰腺炎大鼠肠道损伤的保护作用及肠组织p38MAPK/NF-κB表达的影响[J]. 中国中医急症, 2019, 28(8): 1378-1382.
[12] 胡传文, 江红娟, 郑小春, 等. 半夏泻心汤结合保留灌肠治疗缓解期溃疡性结肠炎及对肠道内菌群水平的影响[J]. 新中医, 2020, 52(3): 10-12.
[13] Zou HY, Ye HQ, Kamaraj R, et al. A review on pharmacological activities and synergistic effect of quercetin with small molecule agents[J]. Phytomedicine, 2021, 92: 153736.
[14] Chen ZG, Yuan QL, Xu GR, et al. Effects of quercetin on proliferation and H2O2 - induced apoptosis of intestinal porcine enterocyte cells[J]. Molecules, 2018, 23(8): 2012.
[15] Bahar E, Kim JY, Yoon H. Quercetin attenuates manganese - induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS/NF-kappa B and HO-1/Nrf2 pathways[J]. Int J Mol Sci, 2017, 18(9): 1989.
[16] Zhang CL, Zhang S, He WX, et al. Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression[J]. Life Sci, 2017, 186: 125-132.
[17] 冯思敏, 宁可, 邵平, 等. β-谷甾醇和豆甾醇对小鼠急性结肠炎的治疗作用研究[J]. 中国粮油学报, 2018, 33(12): 80-86.
[18] Hayden MS, Ghosh S. NF-kappa B in immunobiology[J]. Cell Res, 2011, 21(2): 223-244.
[19] Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress[J]. CNS Neurol Disord Drug Targets, 2014, 13(9): 1615-1626.
[20] Achkar JP, Dassopoulos T, Silverberg MS, et al. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus[J]. Am J Gastroenterol, 2006, 101(3): 572-580.
[21] Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease[J]. Apoptosis, 2009, 14(4): 536-548.
[22] Scatena R, Bottoni P, Botta G, et al. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic[J]. Am J Physiol Cell Physiol, 2007, 293(1): C12-C21.
[23] 钟文洲, 林松挺, 陈正义, 等. 溃疡性结肠炎中Gal-3与BCL-2表达的意义[J]. 临床与实验病理学杂志, 2017, 33(12): 1328-1332.
[24] Boal CP, Cotter J. Mucosal healing in ulcerative colitis: a comprehensive review[J]. Drugs, 2017, 77(2): 159-173.
[25] Huang WC, Liang J, Nagahashi M, et al. Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans[J]. FASEB J, 2016, 30(8): 2945-2958.
[26] 张瀚文, 石岩. 黄芪-红参治疗糖尿病视网膜病变的潜在靶点及网络药理学作用机制研究[J]. 中华中医药学刊, 2021, 39(5): 101-106.
[27] Hacker G, Paschen SA. Therapeutic targets in the mitochondrial apoptotic pathway[J]. Expert Opin Ther Targets, 2007, 11(4): 515-526.
[28] 唐松涛. 胰高血糖素样肽-1对晚期糖基化终末产物诱导血管内皮细胞肌球蛋白轻链磷酸化的影响及机制研究[D]. 合肥: 安徽医科大学, 2016.
[29] Muniraju M, Mutsvunguma LZ, Foley J, et al. Kaposi Sarcoma - associated herpesvirus glycoprotein H is indispensable for infection of epithelial, endothelial, and fibroblast cell types[J]. J Virol, 2019, 93(16): e00630-19.
[30] Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells[J]. Nat Med, 1995, 1(12): 1274-1278.
[31] Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma[J]. Proc Natl Acad Sci USA, 1999, 96(8): 4546-4551.
[32] Veettil MV, Bandyopadhyay C, Dutta D, et al. Interaction of KSHV with host cell surface receptors and cell entry[J]. Viruses, 2014,6(10):4024-4046.
[33] Bechtel JT, Liang Y, Hvidding J, et al. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells[J]. J Virol, 2003, 77(11): 6474-6481.
[34] Yu XL, Sha JF, Xiang S, et al. Suppression of KSHV-induced angiopoietin-2 inhibits angiogenesis, infiltration of inflammatory cells, and tumor growth[J]. Cell Cycle, 2016, 15(15): 2053-2065.
[35] Bhaskaran N, Ghosh SK, Yu X, et al. Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages[J]. Cell Cycle, 2017, 16(17): 1611-1621.
[36] Xie YB, Shi XF, Sheng K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)[J]. Mol Med Rep, 2019, 19(2): 783-791.
[37] Sun K, Luo J, Guo J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review[J]. Osteoarthritis Cartilage, 2020, 28(4): 400-409.
[38] So T, Ishii N. The TNF-TNFR family of co-signal molecules[J]. Adv Exp Med Biol, 2019, 1189: 53-84.
